メトホルミン-ピオグリタゾンの世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9101813）

◆英語タイトル：Global Metformin-Pioglitazone Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9101813
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：122
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、メトホルミン-ピオグリタゾンの世界市場について調べ、まとめました。種類別セグメントは、錠剤：15 mgピオグリタゾン/ 1000 mgメトホルミンHCl、錠剤：30 mgピオグリタゾン/ 1000 mgメトホルミンHCl等、用途別セグメントは、病院、薬局等に区分しました。メトホルミン-ピオグリタゾンの世界市場概観、企業動向、企業別メトホルミン-ピオグリタゾンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・メトホルミン-ピオグリタゾンの市場概観
・メトホルミン-ピオグリタゾンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・メトホルミン-ピオグリタゾンの企業別販売動向、市場シェア、市場集中度、競争動向
・メトホルミン-ピオグリタゾンの世界市場規模
・メトホルミン-ピオグリタゾンの北米市場分析（アメリカ、カナダ、メキシコ等）
・メトホルミン-ピオグリタゾンのアメリカ市場規模推移
・メトホルミン-ピオグリタゾンのカナダ市場規模推移
・メトホルミン-ピオグリタゾンのメキシコ市場規模推移
・メトホルミン-ピオグリタゾンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・メトホルミン-ピオグリタゾンのドイツ市場規模推移
・メトホルミン-ピオグリタゾンのイギリス市場規模推移
・メトホルミン-ピオグリタゾンのロシア市場規模推移
・メトホルミン-ピオグリタゾンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・メトホルミン-ピオグリタゾンの日本市場規模推移
・メトホルミン-ピオグリタゾンの中国市場規模推移
・メトホルミン-ピオグリタゾンの韓国市場規模推移
・メトホルミン-ピオグリタゾンのインド市場規模推移
・メトホルミン-ピオグリタゾンの東南アジア市場規模推移
・メトホルミン-ピオグリタゾンの南米市場分析（ブラジル、アルゼンチン等）
・メトホルミン-ピオグリタゾンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・メトホルミン-ピオグリタゾンの種類別分析/販売量、売上、市場シェア（錠剤：15 mgピオグリタゾン/ 1000 mgメトホルミンHCl、錠剤：30 mgピオグリタゾン/ 1000 mgメトホルミンHCl）
・メトホルミン-ピオグリタゾンの用途別分析/市場規模（病院、薬局）
・メトホルミン-ピオグリタゾンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・メトホルミン-ピオグリタゾンの販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Metformin/pioglitazone is used to lower blood sugar levels in type 2 diabetes. It’s used along with diet and exercise.

Scope of the Report:
The global Metformin-Pioglitazone market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metformin-Pioglitazone.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Metformin-Pioglitazone market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metformin-Pioglitazone market by product type and applications/end industries.

Market Segment by Companies, this report covers
Takeda Pharmaceuticals
Mylan
Teva
Sandoz
Aurobindo Pharma
MACLEODS
Torrent Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tablets: 15 mg pioglitazone/1000 mg metformin HCl
Tablets: 30 mg pioglitazone/1000 mg metformin HCl

Market Segment by Applications, can be divided into
Hospital
Drug store

【レポートの目次】

Table of Contents

1 Metformin-Pioglitazone Market Overview
1.1 Product Overview and Scope of Metformin-Pioglitazone
1.2 Classification of Metformin-Pioglitazone by Types
1.2.1 Global Metformin-Pioglitazone Revenue Comparison by Types (2019-2024)
1.2.2 Global Metformin-Pioglitazone Revenue Market Share by Types in 2018
1.2.3 Tablets: 15 mg pioglitazone/1000 mg metformin HCl
1.2.4 Tablets: 30 mg pioglitazone/1000 mg metformin HCl
1.3 Global Metformin-Pioglitazone Market by Application
1.3.1 Global Metformin-Pioglitazone Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Metformin-Pioglitazone Market by Regions
1.4.1 Global Metformin-Pioglitazone Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Metformin-Pioglitazone Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Metformin-Pioglitazone Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metformin-Pioglitazone Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Metformin-Pioglitazone Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metformin-Pioglitazone Status and Prospect (2014-2024)
1.5 Global Market Size of Metformin-Pioglitazone (2014-2024)
2 Manufacturers Profiles
2.1 Takeda Pharmaceuticals
2.1.1 Business Overview
2.1.2 Metformin-Pioglitazone Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Takeda Pharmaceuticals Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
2.2 Mylan
2.2.1 Business Overview
2.2.2 Metformin-Pioglitazone Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Mylan Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva
2.3.1 Business Overview
2.3.2 Metformin-Pioglitazone Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sandoz
2.4.1 Business Overview
2.4.2 Metformin-Pioglitazone Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sandoz Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
2.5 Aurobindo Pharma
2.5.1 Business Overview
2.5.2 Metformin-Pioglitazone Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Aurobindo Pharma Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
2.6 MACLEODS
2.6.1 Business Overview
2.6.2 Metformin-Pioglitazone Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MACLEODS Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
2.7 Torrent Pharmaceuticals
2.7.1 Business Overview
2.7.2 Metformin-Pioglitazone Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Torrent Pharmaceuticals Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
3 Global Metformin-Pioglitazone Market Competition, by Players
3.1 Global Metformin-Pioglitazone Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Metformin-Pioglitazone Players Market Share
3.2.2 Top 10 Metformin-Pioglitazone Players Market Share
3.3 Market Competition Trend
4 Global Metformin-Pioglitazone Market Size by Regions
4.1 Global Metformin-Pioglitazone Revenue and Market Share by Regions
4.2 North America Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
4.3 Europe Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
4.5 South America Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
5 North America Metformin-Pioglitazone Revenue by Countries
5.1 North America Metformin-Pioglitazone Revenue by Countries (2014-2019)
5.2 USA Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
5.3 Canada Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
5.4 Mexico Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
6 Europe Metformin-Pioglitazone Revenue by Countries
6.1 Europe Metformin-Pioglitazone Revenue by Countries (2014-2019)
6.2 Germany Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
6.3 UK Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
6.4 France Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
6.5 Russia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
6.6 Italy Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Metformin-Pioglitazone Revenue by Countries
7.1 Asia-Pacific Metformin-Pioglitazone Revenue by Countries (2014-2019)
7.2 China Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
7.3 Japan Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
7.4 Korea Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
7.5 India Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
8 South America Metformin-Pioglitazone Revenue by Countries
8.1 South America Metformin-Pioglitazone Revenue by Countries (2014-2019)
8.2 Brazil Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
8.3 Argentina Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
8.4 Colombia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Metformin-Pioglitazone by Countries
9.1 Middle East and Africa Metformin-Pioglitazone Revenue by Countries (2014-2019)
9.2 Saudi Arabia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
9.3 UAE Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
9.4 Egypt Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
9.5 Nigeria Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
9.6 South Africa Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
10 Global Metformin-Pioglitazone Market Segment by Type
10.1 Global Metformin-Pioglitazone Revenue and Market Share by Type (2014-2019)
10.2 Global Metformin-Pioglitazone Market Forecast by Type (2019-2024)
10.3 Tablets: 15 mg pioglitazone/1000 mg metformin HCl Revenue Growth Rate (2014-2024)
10.4 Tablets: 30 mg pioglitazone/1000 mg metformin HCl Revenue Growth Rate (2014-2024)
11 Global Metformin-Pioglitazone Market Segment by Application
11.1 Global Metformin-Pioglitazone Revenue Market Share by Application (2014-2019)
11.2 Metformin-Pioglitazone Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Metformin-Pioglitazone Market Size Forecast (2019-2024)
12.1 Global Metformin-Pioglitazone Market Size Forecast (2019-2024)
12.2 Global Metformin-Pioglitazone Market Forecast by Regions (2019-2024)
12.3 North America Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
12.4 Europe Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
12.6 South America Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Metformin-Pioglitazone Picture
Table Product Specifications of Metformin-Pioglitazone
Table Global Metformin-Pioglitazone and Revenue (Million USD) Market Split by Product Type
Figure Global Metformin-Pioglitazone Revenue Market Share by Types in 2018
Figure Tablets: 15 mg pioglitazone/1000 mg metformin HCl Picture
Figure Tablets: 30 mg pioglitazone/1000 mg metformin HCl Picture
Table Global Metformin-Pioglitazone Revenue (Million USD) by Application (2014-2024)
Figure Metformin-Pioglitazone Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Metformin-Pioglitazone Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Metformin-Pioglitazone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Metformin-Pioglitazone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Metformin-Pioglitazone Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Metformin-Pioglitazone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Metformin-Pioglitazone Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Metformin-Pioglitazone Revenue (Million USD) and Growth Rate (2014-2024)
Table Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceuticals Metformin-Pioglitazone Type and Applications
Table Takeda Pharmaceuticals Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Metformin-Pioglitazone Type and Applications
Table Mylan Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Metformin-Pioglitazone Type and Applications
Table Teva Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
Table Sandoz Basic Information, Manufacturing Base and Competitors
Table Sandoz Metformin-Pioglitazone Type and Applications
Table Sandoz Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Metformin-Pioglitazone Type and Applications
Table Aurobindo Pharma Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
Table MACLEODS Basic Information, Manufacturing Base and Competitors
Table MACLEODS Metformin-Pioglitazone Type and Applications
Table MACLEODS Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
Table Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Torrent Pharmaceuticals Metformin-Pioglitazone Type and Applications
Table Torrent Pharmaceuticals Metformin-Pioglitazone Revenue, Gross Margin and Market Share (2017-2018)
Table Global Metformin-Pioglitazone Revenue (Million USD) by Players (2014-2019)
Table Global Metformin-Pioglitazone Revenue Share by Players (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Share by Players in 2017
Figure Global Metformin-Pioglitazone Revenue Share by Players in 2018
Figure Global Top 5 Players Metformin-Pioglitazone Revenue Market Share in 2018
Figure Global Top 10 Players Metformin-Pioglitazone Revenue Market Share in 2018
Figure Global Metformin-Pioglitazone Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Metformin-Pioglitazone Revenue (Million USD) by Regions (2014-2019)
Table Global Metformin-Pioglitazone Revenue Market Share by Regions (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Market Share by Regions (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Market Share by Regions in 2018
Figure North America Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Europe Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure South America Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Table North America Metformin-Pioglitazone Revenue by Countries (2014-2019)
Table North America Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure North America Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure North America Metformin-Pioglitazone Revenue Market Share by Countries in 2018
Figure USA Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Canada Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Mexico Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Table Europe Metformin-Pioglitazone Revenue (Million USD) by Countries (2014-2019)
Figure Europe Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure Europe Metformin-Pioglitazone Revenue Market Share by Countries in 2018
Figure Germany Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure UK Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure France Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Russia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Italy Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Metformin-Pioglitazone Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Metformin-Pioglitazone Revenue Market Share by Countries in 2018
Figure China Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Japan Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Korea Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure India Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Table South America Metformin-Pioglitazone Revenue by Countries (2014-2019)
Table South America Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure South America Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure South America Metformin-Pioglitazone Revenue Market Share by Countries in 2018
Figure Brazil Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Argentina Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Colombia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Metformin-Pioglitazone Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Metformin-Pioglitazone Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Metformin-Pioglitazone Revenue Market Share by Countries in 2018
Figure Saudi Arabia Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure UAE Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Egypt Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure Nigeria Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Figure South Africa Metformin-Pioglitazone Revenue and Growth Rate (2014-2019)
Table Global Metformin-Pioglitazone Revenue (Million USD) by Type (2014-2019)
Table Global Metformin-Pioglitazone Revenue Share by Type (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Share by Type (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Share by Type in 2019
Table Global Metformin-Pioglitazone Revenue Forecast by Type (2019-2024)
Figure Global Metformin-Pioglitazone Market Share Forecast by Type (2019-2024)
Figure Global Tablets: 15 mg pioglitazone/1000 mg metformin HCl Revenue Growth Rate (2014-2019)
Figure Global Tablets: 30 mg pioglitazone/1000 mg metformin HCl Revenue Growth Rate (2014-2019)
Table Global Metformin-Pioglitazone Revenue by Application (2014-2019)
Table Global Metformin-Pioglitazone Revenue Share by Application (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Share by Application (2014-2019)
Figure Global Metformin-Pioglitazone Revenue Share by Application in 2019
Table Global Metformin-Pioglitazone Revenue Forecast by Application (2019-2024)
Figure Global Metformin-Pioglitazone Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Metformin-Pioglitazone Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Metformin-Pioglitazone Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Metformin-Pioglitazone Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
Figure Europe Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
Figure South America Metformin-Pioglitazone Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Metformin-Pioglitazone Revenue Market Forecast (2019-2024)

【掲載企業】

Takeda Pharmaceuticals、Mylan、Teva、Sandoz、Aurobindo Pharma、MACLEODS、Torrent Pharmaceuticals、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ メトホルミン-ピオグリタゾンの世界市場2019(Global Metformin-Pioglitazone Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp